NT-proBNP for risk prediction of cardiovascular events and all-cause mortality: The getABI-study
Authors:
Open Access
- 1 August 2020
- journal article
- research article
- Published by Elsevier in IJC Heart & Vasculature
- Vol. 29, 100553
Abstract
No abstract availableKeywords
Funding Information
- Abbott
- Sanofi
This publication has 20 references indexed in Scilit:
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureEuropean Heart Journal, 2016
- B‐type natriuretic peptide predicts stroke of presumable cardioembolic origin in addition to coronary artery calcificationEuropean Journal of Neurology, 2014
- B-type natriuretic peptide: distribution in the general population and the association with major cardiovascular and coronary events—The Heinz Nixdorf Recall StudyClinical Research in Cardiology, 2013
- Predictive Utility of Atrial, N-Terminal Pro-Atrial, and N-Terminal Pro-B-Type Natriuretic Peptides for Mortality and Cardiovascular Events in the General Community: A 9-Year Follow-up StudyMayo Clinic Proceedings, 2011
- N-Terminal Pro–B-Type Natriuretic Peptide-Guided Treatment for Chronic Heart FailureJACC, 2009
- B-Type Natriuretic Peptides and Cardiovascular RiskCirculation, 2009
- NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patientsNephrology Dialysis Transplantation, 2009
- N-Terminal Fragment of the Prohormone Brain-Type Natriuretic Peptide (NT-proBNP), Cardiovascular Events, and Mortality in Patients With Stable Coronary Heart DiseaseJAMA, 2007
- N-Terminal Pro-Brain Natriuretic Peptide, C-Reactive Protein, and Urinary Albumin Levels as Predictors of Mortality and Cardiovascular Events in Older AdultsJAMA, 2005
- Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and DeathNew England Journal of Medicine, 2004